Buchér J B, Thomas K M, Guzman D, Riley E, Dela Cruz N, Bangsberg D R
University of California, San Francisco (UCSF) School of Medicine, San Francisco, CA 94143, USA.
HIV Med. 2007 Jan;8(1):28-31. doi: 10.1111/j.1468-1293.2007.00423.x.
BACKGROUND: Standard two-step HIV testing is limited by poor return-for-results rates and misses high-risk individuals who do not access conventional testing facilities. METHODS: We describe a community-based rapid HIV testing programme in which homeless and marginally housed adults recruited from shelters, free meal programmes and single room occupancy hotels in San Francisco received OraQuick Rapid HIV-1 Antibody testing (OraSure Technologies, Bethlehem, PA, USA). RESULTS: Over 8 months, 1614 adults were invited to participate and 1213 (75.2%) underwent testing. HIV seroprevalence was 15.4% (187 of 1213 individuals) overall and 3.5% (37 of 1063) amongst high-risk individuals reporting no previous testing, a prior negative test, or previous testing without result disclosure. All 1213 participants received their results. Of 30 newly diagnosed persons who received confirmatory results, 26 (86.7%) reported at least one contact with a primary healthcare provider in the 6 months following diagnosis. CONCLUSIONS: We conclude that community-based rapid testing is feasible, acceptable and effective based on the numbers of high-risk persons tested over a short period, the participation rate, the prevalence of new infection, the rate of result disclosure, and the proportion linked to care.
背景:标准的两步式HIV检测受结果反馈率低的限制,且会遗漏那些未使用传统检测设施的高危个体。 方法:我们描述了一项基于社区的快速HIV检测项目,从旧金山的收容所、免费膳食项目和单人房间入住酒店招募的无家可归和居住条件差的成年人接受了奥然快速HIV-1抗体检测(美国宾夕法尼亚州伯利恒市奥然科技公司)。 结果:在8个月的时间里,1614名成年人被邀请参与,1213人(75.2%)接受了检测。总体HIV血清阳性率为15.4%(1213人中的187人),在报告此前未检测、此前检测结果为阴性或此前检测但结果未告知的高危个体中为3.5%(1063人中的37人)。所有1213名参与者都收到了检测结果。在30名获得确诊结果的新诊断患者中,26人(86.7%)报告在诊断后的6个月内至少与一名初级医疗服务提供者有过一次接触。 结论:基于短期内检测的高危人数、参与率、新感染率、结果告知率以及与医疗服务的关联比例,我们得出结论,基于社区的快速检测是可行、可接受且有效的。
J Gen Intern Med. 2004-4
Am J Public Health. 2004-7
Front Public Health. 2021
Public Health Rep. 2016-9